Jang-Ho Cha, MD, PhD
Dr. Cha is the Global Head Translational Medicine, Neuroscience at Novartis Institute for BioMedical Research. Dr. Cha obtained his M.D and Ph.D. from the University of Michigan and did his residency in Neurology at Massachusetts General Hospital in Boston, MA. During his career at Massachusetts General Hospital at the New England HDSA Center of Excellence, Dr. Cha held multiple positions culminating in Associate Professor of Neurology.
Active in the HD community, he has held several leadership positions, such as Chair of HDSA’s National Board of Trustees, Chair of the Gordon Research Conference on ‘CAG Triplet Repeat Disorders’ and chair of the Huntington Study Group HD Clinical Research Symposium. Internationally he has worked with the US-Venezuela Collaborative Huntington’s Disease Project for Hereditary Disease Foundation and with the Huntington Study Group. Dr. Cha is a regular speaker for the Huntington’s Disease Society of America and has presented regularly at the Annual HDSA Convention, local Chapter educational events and support groups and on a Caregiver’s Corner webinar.